NCT05912114

Brief Summary

For patients with inadequate bowel preparation, current guidelines recommend either remedial measures or rescheduling the endoscopy, but previous surveys have found that approximately 30% of patients do not follow medical advice to reschedule the examination if it is rescheduled, while those who take remedial measures on the same day are more compliant, so remedial measures may be a better option than rescheduling the examination. As for the remedy regimen, it has been demonstrated that oral PEG is superior to the enema regimen in terms of bowel cleansing, but PEG is very resistant to be taken by most patients due to its poor taste and the larger doses required, resulting in poor bowel preparation and poor compliance. In contrast, oral mannitol has the advantages of small dose and good taste, and patient compliance may be higher.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
134

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 12, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

1.6 years

First QC Date

June 12, 2023

Last Update Submit

June 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bowel cleanliness

    The BBPS scoring method, defined as a score of ≥2 for each bowel segment, was used to consider the preparation adequate.

    1 hour

Secondary Outcomes (1)

  • Patients' feelings

    1 hour

Other Outcomes (1)

  • Patients' willingness to take such measures again.

    1 hour

Study Arms (2)

Mannitol

EXPERIMENTAL

Use of oral 1L Mannitol for remediation of intestinal uncleanliness

Drug: Mannitol

Polyethylene glycol electrolyte

ACTIVE COMPARATOR

Use of oral 1L PEG for remediation of intestinal uncleanliness

Drug: Polyethylene glycol electrolyte

Interventions

Mannitol, as an osmotic laxative, increases the colloid osmotic pressure in the intestinal lumen, which results in a hyperosmolar state in the intestine, thus allowing easy elimination of stools.

Mannitol

Polyethylene glycol electrolyte is an inert polymer that cannot be absorbed by the body itself. Due to its high permeability, it retains water in the intestinal tract, increasing the amount of fluid retained in the intestine and softening the stool, thus acting as a diuretic.

Polyethylene glycol electrolyte

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18-75 years with a pre-first colonoscopy bowel cleanliness of less than 2 points in any segment of the bowel.

You may not qualify if:

  • \- (1) Pregnant women. (2) History of colorectal surgery. (3) Patients with acute exacerbation of inflammatory bowel disease. (4) Patients with severe medical conditions that make them unsuitable for colonoscopy.
  • (5) Patients with known allergy to mannitol/PEG. (6) Patients who refuse to sign the informed consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ningbo first hospital

Ningbo, Zhejiang, 315000, China

RECRUITING

Related Publications (1)

  • Zheng S, Xu Z, Deng F, Wang S, Qian T, Lin P, Wang C, Wang W, Xia Y, Xu L, Zhang Z. Comparing the efficacy of mannitol and polyethylene glycol in treating patients with poor bowel preparation: a randomized controlled clinical study. Tech Coloproctol. 2025 Dec 24;30(1):15. doi: 10.1007/s10151-025-03243-y.

MeSH Terms

Interventions

Mannitolglycoprep

Intervention Hierarchy (Ancestors)

Sugar AlcoholsAlcoholsOrganic ChemicalsCarbohydrates

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2023

First Posted

June 22, 2023

Study Start

June 10, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

June 22, 2023

Record last verified: 2023-06

Locations